Technical Principles and Applications of UA-Glo® Caspase 3/7 Assay Kit

I. Introduction

Apoptosis, as a genetically regulated programmed cell death process, plays a crucial role in the development, homeostasis, and disease progression of multicellular organisms. Among the various apoptosis-related molecules, Caspase 3 and Caspase 7, as effector cysteine proteases, are positioned at the downstream execution phase of the apoptotic cascade. Once activated by upstream signals, they cleave multiple cellular substrates, leading to characteristic apoptotic morphological changes such as cytoskeletal disintegration and DNA fragmentation. Therefore, the activation of Caspase 3/7 is considered a hallmark event of cells entering the irreversible apoptotic program, and their activity levels are a core quantitative indicator for assessing the extent of apoptosis.

II. Detection Principle and Technical Basis

The UA-Glo® Caspase 3/7 Assay Kit employs a luminescence-based homogeneous detection system. Its core design lies in a specialized substrate molecule, which consists of a Caspase 3/7-specific recognition tetrapeptide sequence (e.g., DEVD) conjugated with aminoluciferin. In the uncleaved state, the aminoluciferin is blocked and cannot react with luciferase. When the reagent is mixed with samples containing active Caspase 3/7, the activated enzymes specifically cleave the tetrapeptide sequence, releasing free aminoluciferin. Subsequently, in the presence of luciferase, ATP, and oxygen provided in the kit, the free aminoluciferin is catalyzed to produce bioluminescent signals. The signal intensity is directly proportional to the Caspase 3/7 activity level in the sample, enabling precise quantification through luminescence measurement.

III. Kit Components and Characteristics

This kit is designed with experimental convenience and result reliability in mind. Its main components include an optimized master reaction mixture, which is pre-mixed with Caspase 3/7 substrate, thermostable luciferase, and cofactors, along with a dedicated reaction buffer. Additionally, the kit provides recombinant active Caspase as a positive control and a specific Caspase inhibitor as a negative control, facilitating experimental validation and exclusion of non-specific signals. All components undergo strict quality control to ensure inter-batch stability and reproducibility.

IV. Experimental Procedure

The assay procedure is simple and efficient, suitable for various throughput requirements.

(1) Sample Preparation

The assay is performed in white opaque microplates to minimize inter-well signal crosstalk. After culturing and treating cells under predetermined conditions, the detection reagent can be directly added to the cell culture medium.

(2) Reagent Addition and Reaction

After reconstituting or diluting the master reaction mixture with the provided buffer, add it to the cell plate at an equal volume ratio (e.g., 100μl of detection reagent per 100μl of culture medium per well). Mix thoroughly by gentle shaking.

(3) Signal Generation and Detection

Incubate at room temperature for 30 minutes to 3 hours, with the exact duration adjustable based on cell type and experimental objectives. After incubation, directly measure photon counts in each well using a microplate reader equipped with a luminescence detection module, without any transfer or washing steps.

(4) Data Analysis

The luminescence values can be directly used to compare Caspase 3/7 activity across different treatment groups. By calculating the ratio of luminescence signals between treated groups and negative controls, the induction fold of apoptosis can be quantified. More precise relative activity calculations can be performed using positive control wells.

V. Main Applications

Given its excellent performance, this kit has broad applications in life sciences and biomedical research.

(1) Anticancer Drug Screening and Evaluation

In early-stage anticancer drug development, the activation of Caspase 3/7 in tumor cells treated with compounds can be rapidly and effectively assessed to screen for apoptosis-inducing candidate molecules and evaluate their efficacy.

(2) Cytotoxicity Mechanism Studies

When cells are exposed to potentially toxic substances, multiplex analysis with cell viability assays can be performed. A significant increase in Caspase 3/7 activity indicates apoptosis, whereas reduced viability without Caspase activation suggests necrosis or other death pathways.

(3) Gene Function Studies

By modulating specific gene expression via RNA interference or overexpression and then using this kit to assess apoptosis, the role of the gene in cell survival and death regulation networks can be investigated.

(4) Neurodegenerative Disease Research

In neuronal apoptosis models, this kit can evaluate whether candidate neuroprotective compounds effectively inhibit Caspase 3/7 activation, thereby delaying or preventing neuronal death.

(5) Immunology and Developmental Biology Research

The kit can be used to study apoptosis in activated immune cells or dynamic changes in apoptosis during embryonic development and tissue remodeling.

VI. Summary

The UA-Glo® Caspase 3/7 Assay Kit combines the high sensitivity of bioluminescence detection with the simplicity of homogeneous operation, providing a powerful quantitative tool for apoptosis research. Its outstanding signal stability and compatibility with other detection methods make it suitable for both fundamental research into apoptotic mechanisms and high-throughput screening in drug discovery. As a key component of cell health analysis, this technology offers reliable support for understanding disease mechanisms and developing novel therapies.

VII. Which Manufacturers Provide the UA-Glo® Caspase 3/7 Assay Kit?

Nanjing UA-Bio Technology Co., Ltd. (UA-Bio) has independently developed the "UA-Glo® Caspase 3/7 Assay", a high-performance bioluminescence detection platform specifically designed for apoptosis mechanism research. This kit, based on the principle of Caspase 3/7-specific substrate cleavage, aims to accurately and efficiently quantify the activation levels of Caspase 3/7 during apoptosis, providing a stable and reliable standardized solution for tumor research, drug screening, and toxicity evaluation.

Nanjing UA-Bio Technology Co., Ltd. is committed to providing cutting-edge, high-quality core reagents and tools for immunology, cell therapy, and innovative drug development. For detailed technical specifications, validation data, or specific application inquiries regarding the "UA-Glo® Caspase 3/7 Assay" (Catalog No.: UA079012), please feel free to contact us.